Search Results - "Moore, G. B. T."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    The relationship between the effects of short‐chain fatty acids on intestinal motility in vitro and GPR43 receptor activation by Dass, N. B., John, A. K., Bassil, A. K., Crumbley, C. W., Shehee, W. R., Maurio, F. P., Moore, G. B. T., Taylor, C. M., Sanger, G. J.

    Published in Neurogastroenterology and motility (01-01-2007)
    “…The G protein‐coupled receptors, GPR41 and GPR43, are activated by short‐chain fatty acids (SCFAs), with distinct rank order potencies. This study investigated…”
    Get full text
    Journal Article
  2. 2

    Adaptive upregulation of gastric and hypothalamic ghrelin receptors and increased plasma ghrelin in a model of cancer chemotherapy-induced dyspepsia by Malik, N.M., Moore, G.B.T., Kaur, R., Liu, Y.-L., Wood, S.L., Morrow, R.W., Sanger, G.J., Andrews, P.L.R.

    Published in Regulatory peptides (05-06-2008)
    “…Chemotherapy treatment can lead to delayed gastric emptying, early satiety, anorexia, nausea and vomiting, described collectively as the cancer-associated…”
    Get full text
    Journal Article
  3. 3

    Behavioural and hypothalamic molecular effects of the anti-cancer agent cisplatin in the rat: A model of chemotherapy-related malaise? by Malik, N.M., Moore, G.B.T., Smith, G., Liu, Y.-L., Sanger, G.J., Andrews, P.L.R.

    “…Many cancer patients receiving chemotherapy experience fatigue, disturbed circadian rhythms, anorexia and a variety of dyspeptic symptoms including nausea…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Energy restriction enhances therapeutic efficacy of the PPARγ agonist, rosiglitazone, through regulation of visceral fat gene expression by Moore, G.B.T, Pickavance, L.C, Briscoe, C.P, Clapham, J.C, Buckingham, R.E, Wilding, J.P.H

    Published in Diabetes, obesity & metabolism (01-03-2008)
    “…Consumption of a palatable diet can induce hyperphagia, leading to weight gain (dietary obesity) and insulin resistance in rats. Thiazolidinediones (TZDs) can…”
    Get full text
    Journal Article
  6. 6

    Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosiglitazone, through regulation of visceral fat gene expression by Moore, G B T, Pickavance, L C, Briscoe, C P, Clapham, J C, Buckingham, R E, Wilding, J P H

    Published in Diabetes, obesity & metabolism (01-03-2008)
    “…Consumption of a palatable diet can induce hyperphagia, leading to weight gain (dietary obesity) and insulin resistance in rats. Thiazolidinediones (TZDs) can…”
    Get full text
    Journal Article
  7. 7

    Plasma leptin concentrations and OB gene expression in subcutaneous adipose tissue are not regulated acutely by physiological hyperinsulinaemia in lean and obese humans by CLAPHAM, J. C, SMITH, S. A, MOORE, G. B. T, HUGHES, M. G, AZAM, H, SCOTT, A, JUNG, R. T

    Published in International Journal of Obesity (01-03-1997)
    “…To determine the effects of obesity on fasting plasma leptin levels and assess the effects of feeding on plasma leptin and OB gene expression in subcutaneous…”
    Get full text
    Journal Article